Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  IQVIA Holdings Inc.    IQV

IQVIA HOLDINGS INC.

(IQV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

IQVIA: 3Q Earnings Snapshot

10/20/2020 | 07:18am EST

DURHAM, N.C. (AP) _ IQVIA Holdings Inc. (IQV) on Tuesday reported third-quarter profit of $101 million.

The Durham, North Carolina-based company said it had profit of 52 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.63 per share.

The results topped Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.51 per share.

The clinical testing company posted revenue of $2.79 billion in the period, also topping Street forecasts. Nine analysts surveyed by Zacks expected $2.75 billion.

For the current quarter ending in December, IQVIA expects its per-share earnings to range from $1.93 to $2.03.

The company said it expects revenue in the range of $3.04 billion to $3.19 billion for the fiscal fourth quarter.

IQVIA expects full-year earnings in the range of $6.25 to $6.35 per share, with revenue ranging from $11.1 billion to $11.25 billion.

IQVIA shares have risen 6% since the beginning of the year. The stock has risen 14% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IQV at https://www.zacks.com/ap/IQV

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about IQVIA HOLDINGS INC.
11/19IQVIA : Q3 2020 Earnings Call - Presentation
PU
11/02IQVIA : 's Orchestrated Customer Engagement Platform Selected by Zentiva to Acce..
BU
10/22IQVIA : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
10/20IQVIA : 3Q Earnings Snapshot
AQ
10/20IQVIA HOLDINGS INC. : Results of Operations and Financial Condition, Financial S..
AQ
10/20IQVIA : Reports Third-Quarter 2020 Results, Raises Full-Year 2020 Guidance and P..
BU
10/15IQVIA HOLDINGS INC. : quaterly earnings release
10/12IQVIA : Joins FDA to Advance COVID-19 Understanding at Community Level through C..
BU
10/07IQVIA : to Announce Third-Quarter Results on October 20, 2020
BU
10/06IQVIA INSTITUTE FOR HUMAN DATA SCIEN : Biosimilars Reach Inflection Point &ndash..
BU
More news
Financials (USD)
Sales 2020 11 206 M - -
Net income 2020 332 M - -
Net Debt 2020 10 414 M - -
P/E ratio 2020 100x
Yield 2020 -
Capitalization 32 829 M 32 829 M -
EV / Sales 2020 3,86x
EV / Sales 2021 3,44x
Nbr of Employees 68 000
Free-Float 74,5%
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 196,26 $
Last Close Price 171,23 $
Spread / Highest target 32,6%
Spread / Average Target 14,6%
Spread / Lowest Target -8,31%
EPS Revisions
Managers
NameTitle
Ari Bousbib Chairman, President & Chief Executive Officer
James Grant Berkshire Senior Vice President-Business Operations
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
John M. Leonard Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IQVIA HOLDINGS INC.10.82%32 829
MODERNA, INC.620.91%55 799
LONZA GROUP AG56.57%45 596
CELLTRION, INC.90.06%41 539
SEAGEN INC.55.27%31 988
IMMUNOMEDICS, INC.315.22%20 324